期刊文献+

基于UPLC/Q-TOF/MS和网络药理学研究甘草渣活性部位治疗溃疡性结肠炎的潜在机制 被引量:1

Potential mechanism of licorice residue active site for the treatment of ulcerative colitis based on UPLC/Q-TOF/MS and net pharmacology
下载PDF
导出
摘要 目的利用UPLC/Q-TOF/MS和网络药理学方法研究甘草渣活性部位(GC)治疗溃疡性结肠炎(ulcerative colitis,UC)的分子机制。方法利用UPLC/Q-TOF/MS分析GC的化学成分;通过DrugBank、CTD、STITCH和SwissTarget数据库收集并预测各化学成分的靶点。通过PharmGKB、NCBI-gene、TTD、CTD和DisGeNET数据库收集与UC相关的靶点。利用Cytoscape 3.6.1构建化学成分-靶点网络;基于String数据库,构建GC治疗UC的靶点相互作用网络,进而通过MCODE聚类分析发现核心网络,利用MCC、Degree和EPC发现关键靶点。利用CTD数据库进行KEGG(KEGG pathway analysis)通路注释分析和GO(gene ontology)生物学过程富集分析。结果GC化学成分-UC靶点网络包含31种化学成分和79个靶点,关键靶点涉及丝氨酸/苏氨酸蛋白激酶1(serine/threonine protein kinase B1,PKB1/AKT1)、白介细胞素6(interleukin 6,IL6)、肿瘤坏死因子(tumor necrosis factor,TNF)、肿瘤蛋白53(tumor protein 53,TP53)、胱天蛋白酶3(caspase 3,CASP3)和信号转导与转录激活因子3(signal transducer and activator of transcription 3,STAT3)等。经KEGG富集筛选得到24条与UC有关的信号通路,主要涉及pathways in cancer信号通路、TNF信号通路和malaria信号通路等;经GO功能富集分析得到20个条目。结论预测了GC治疗UC的可能作用机制,为进一步寻找有效成分和作用机制奠定了基础。 Objective To study the mechanism of licorice residue active site(GC)in the treatment of ulcerative colitis(UC)by using UPLC/Q-TOF/MS and net pharmacology.Methods Chemical components of GC were analyzed by using UPLC/Q-TOF/MS.Targets of each component in GC were searched and predicted based on DrugBank,CTD,STITCH and SwissTarget databases.UC related targets were screened through PharmGKB,NCBI-gene,TTD,CTD and DisGeNET databases.The compound-target network was constructed using Cytoseape 3.6.1.A target interaction network for GC on UC was constructed based on String database,the core network was found by using MCODE cluster analysis,and the key targets were found based on using MCC,Degree and EPC.KEGG(KEGG pathway analysis)pathway annotation analysis and GO(gene ontology)biological process enrichment analysis were performed based on CTD database.Results There are 31 components and 79 targets in GC compound-target network,and the key targets include AKTI,IL6,TNF,TP53,CASP3 STAT3 and so on.KEGG pathway enrichment screening resulted in 24 associations with UC,mainly involving cancer pathway,TNF pathway and malaria pathway,and Go functional enrichment analysis yielded 20 GO terms.Conclusion The main possible mechanism of GC in treating UC was predicted,which lay a foundation for the identification of effective components and the mechanism of action.
作者 张娟 徐晓琴 王钧篪 孙宇 斯建勇 卿德刚 ZHANG Juan;XU Xiaoqin;WANG Junchi;SUN Yu;SI Jianyong;QING Degang(Chinese Academy of Medical Sciences and Peking Union Medical College,Institute of Medicinal Plant Development,Beijing 100193,China;Xinjiang Institute of Chinese Materia Medica and Ethnodrug,Urumqi 830002,China)
出处 《西北药学杂志》 CAS 2021年第6期903-909,共7页 Northwest Pharmaceutical Journal
基金 国家自然科学基金项目(编号:81660654) 新疆科技支疆项目(编号:2018E02071) 天山青年计划项目(编号:2017Q066)。
关键词 网络药理学 甘草渣活性部位 溃疡性结肠炎 作用机制 net pharmacology licorice residue active site ulcerative colitis mechanism of action
  • 相关文献

参考文献3

二级参考文献12

  • 1Gordon M,El-Kalla M,Zhao Y,et al.The Tumor Suppressor gene,RASSF1A,is essential for protection against inflammation-induced injury. PLo S One . 2013
  • 2Karatzas P S,Gazouli M,Safioleas M, et al.DNA methylation changes in inflammatory bowel disease. Ann Gastroenterol . 2014
  • 3Hey-Joo Kang,Zhaohui Feng,Yvonne Sun,Gurinder Atwal,Maureen E. Murphy,Timothy R. Rebbeck,Zev Rosenwaks,Arnold J. Levine,Wenwei.Single-nucleotide polymorphisms in the p53 pathway regulate fertility in humans. Proceedings of the National Academy of Sciences of the United States of America . 2009
  • 4Vousden KH,Lu X.Live or let die: the cell’s response to p53. Nature Reviews Cancer . 2002
  • 5Catherine Whibley,Paul D. P. Pharoah,Monica Hollstein.p53 polymorphisms: cancer implications. Nature Reviews Cancer . 2009
  • 6Mir,a Thomas,Ann Kalita,Sylvie Labrecque,David Pim,Lawrence Banks,Greg Matlashews.Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically. Molecular and Cellular Biology . 1999
  • 7Pastorelli L,De Salvo C,Mercado JR,Vecchi M,Pizarro TT.Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation:lessons learned from animal models and human genetics. Front Immunol . 2013
  • 8Schneider-Stock R,,Boltze C,Peters B,Szibor R,Landt O,Meyer F,Roessner A.Selective loss of codon 72 proline p53 and frequent mutational inactivation of the retained arginine allele in colorectal cancer. Neoplasia . 2004
  • 9D?britz J,Menheniott TR.Linking immunity,epigenetics,and cancer in inflammatory bowel disease. Inflammatory Bowel Diseases . 2014
  • 10Harris N,Brill E,Shohat O,Prokocimer M,Wolf D,Arai N,Rotter V.Molecular basis for heterogeneity of the human p53 protein. Molecular and Cellular Probes . 1986

共引文献38

同被引文献95

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部